Please use this identifier to cite or link to this item:
192.168.6.56/handle/123456789/417| Title: | Gendering Drugs |
| Authors: | Ericka Johnson |
| Keywords: | Feminist Studies |
| Issue Date: | 2017 |
| Publisher: | Palgrave Macmillan |
| Description: | The title of this volume, Gendering Drugs, is a double entendre. It speaks to the idea that pharmaceuticals can be gendered—perceived as being masculine or feminine, for men or women—by the bodies and symptoms they are supposed to treat, by market forces and marketing campaigns, and by user demographics. Just think of the infamous little blue pill, Viagra, and the attempts to sell a pink version of the same blockbuster drug (Cacchioni 2015). The other meaning in the title suggests the ways that pharmaceuticals create gendered subjectivities for us, the users. Pharmaceuticals can articulate gendered values, norms, behaviors and expectations that we as users (or misusers, or resisters) must respond to in some way. Drugs can be gendered and they can engender us |
| URI: | http://10.6.20.12:80/handle/123456789/417 |
| ISBN: | 978-3-319-51487-1 |
| Appears in Collections: | Social Work |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.